APVO Stock Analysis: Buy, Sell, or Hold?
APVO - Aptevo Therapeutics Inc
$4.63
-0.12 (-2.53%)
▼
5d:
-1.49%
30d:
-8.13%
90d:
+3.12%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When APVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: APVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: APVO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: APVO is currently trading at $4.63, which is considered oversold relative to its 30-day fair value range of $4.63 to $5.00.
Technical Outlook: Technically, APVO is in a strong downtrend. The price is currently testing key support at $4.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APVO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.50 (+450.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APVO is in a strong downtrend. The price is currently testing key support at $4.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APVO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.50 (+450.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.63 -
$5.00
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 450.8% below Wall St target ($25.50)
Trading Range Analysis
30-Day Trading Range
$4.63 -
$5.00
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.50
Resistance Level
$4.98
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.22
Wall Street Target
$25.50
(+450.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 23, 2026 9:34 PM ET
Data refreshes hourly during market hours. Next update: 10:34 PM
Data refreshes hourly during market hours. Next update: 10:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 65 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 61 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 61 BUY |
